Daniel Grosslight
Stock Analyst at Citigroup
(0)
# 954
Out of 1,030 analysts
119
Total ratings
31.91%
Success rate
-13.24%
Average return
Main Sectors:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
McKesson | Maintains: Strong Buy | 630 713 | 577.13 | 23.54% | 6 | Nov 13, 2024 | |
Health Catalyst | Maintains: Strong Buy | 9 11 | 7.99 | 31.41% | 7 | Nov 13, 2024 | |
GoodRx Holdings | Maintains: Buy | 10 7 | 4.71 | 48.62% | 6 | Nov 13, 2024 | |
Evolent Health | Maintains: Buy | 33 21 | 11.37 | 84.7% | 3 | Nov 13, 2024 | |
Agilon Health | Maintains: Sell | 3 2 | 2.23 | -21.52% | 3 | Nov 13, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 21 19 | 13.88 | 33.29% | 5 | Nov 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 18 10 | 7.37 | 35.69% | 8 | Sep 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 115 107 | 117.97 | -9.3% | 4 | Jul 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 16 20 | 29.8 | -32.89% | 6 | May 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 20.83 | 20.02% | 1 | Apr 22, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 17 10 | 3.37 | 178.93% | 10 | Apr 16, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 | n/a | n/a | 2 | Mar 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 21 19 | 10.41 | 82.52% | 10 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 37 | 24.96 | 48.24% | 5 | Sep 7, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 9 10 | 5.68 | 76.06% | 7 | Aug 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 7 8 | 10.75 | -25.58% | 7 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 185 195 | n/a | n/a | 2 | May 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 2.77 | -54.87% | 5 | Apr 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Sep 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 2 | n/a | n/a | 1 | Sep 20, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 14 18 | n/a | n/a | 2 | Jul 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 125 38 | n/a | n/a | 1 | May 13, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 7 4 | 3.27 | 7.03% | 2 | Nov 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 37 | n/a | n/a | 4 | Dec 22, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 125 170 | n/a | n/a | 2 | Aug 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 24 26 | n/a | n/a | 6 | Aug 11, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 13 | 9.53 | 36.41% | 1 | Dec 11, 2019 |